CL logo

Cresco Labs Inc. Stock Price

CNSX:CL Community·CA$582.5m Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author

CL Share Price Performance

CA$1.64
0.73 (80.22%)
CA$2.42
Fair Value
CA$1.64
0.73 (80.22%)
32.3% undervalued intrinsic discount
CA$2.42
Fair Value
Price CA$1.64
AnalystConsensusTarget CA$2.42
AnalystLowTarget CA$1.92
AnalystHighTarget CA$3.25

CL Community Narratives

·
Fair Value CA$2.42 32.3% undervalued intrinsic discount

Expanding Legal Markets Will Spur Cannabis Consolidation

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value CA$1.92 14.8% undervalued intrinsic discount

Cannabis Markets Will Battle Price Compression While Gaining Cautious Relief

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value CA$3.25 49.6% undervalued intrinsic discount

Rising Cannabis Legalization And Wellness Trends Will Fuel Expansion

0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
CA$1.92
14.8% undervalued intrinsic discount
Profit Margin
3.81%
Future PE
25.66x
Price in 2029
CA$2.33

Trending Discussion

Updated Narratives

CL logo

CL: Discount-Adjusted Outlook Will Support Future Upside From Speculative Buy Rating

Fair Value: CA$2.42 32.3% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CL logo

CL: Lower P/E Assumptions Will Support A More Upside-Skewed Outlook

Fair Value: CA$1.92 14.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CL logo

Rising Cannabis Legalization And Wellness Trends Will Fuel Expansion

Fair Value: CA$3.25 49.6% undervalued intrinsic discount
0 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with mediocre balance sheet.

3 Risks
2 Rewards

Cresco Labs Inc. Key Details

US$655.8m

Revenue

US$331.3m

Cost of Revenue

US$324.6m

Gross Profit

US$460.0m

Other Expenses

-US$135.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-0.37
49.49%
-20.65%
132.1%
View Full Analysis

About CL

Founded
n/a
Employees
2900
CEO
Charles Bachtell
WebsiteView website
www.crescolabs.com

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

Recent CL News & Updates

Recent updates

No updates